PHI with Pharyngeal polyps
How does this condition affect your private health insurance?
Rachenpolypen, or adenoids, are lymphatic tissues in the nasopharynx, behind the nose. Common in children, they often shrink by adolescence. When enlarged, they can obstruct nasal breathing, leading to chronic mouth breathing, snoring, restless sleep, and obstructive sleep apnea. They may also block Eustachian tubes, causing recurrent middle ear infections and hearing loss. Persistent obstruction can contribute to "adenoid facies." Diagnosis involves an ENT examination, sometimes with endoscopy. If symptoms are severe and persistent, surgical removal (adenoidectomy) is the primary treatment, offering significant relief from respiratory and auditory issues and preventing further complications.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months, typically.
Duration of Illness (Lifetime)
Usually a single episode resolving with age or treatment; rarely recurs.
Cost of Treatment (Initial)
Approximately 1,500 - 5,000 USD for diagnosis and adenoidectomy, varying by region and insurance.
Cost of Treatment (Lifetime)
Primarily the cost of the initial treatment; potential for additional costs if complications (e.g., hearing aids, speech therapy) or recurrence occur, estimated up to 7,000 USD in total.
Mortality Rate
Extremely low; virtually non-existent directly from enlarged adenoids.
Risk of Secondary Damages
Moderate (20-50%) if untreated, including conductive hearing loss, chronic sinusitis, dental malocclusion, and speech development issues. Severe obstructive sleep apnea can also have long-term systemic effects.
Probability of Full Recovery
Very high (over 95%) with appropriate and timely surgical intervention (adenoidectomy).
Underlying Disease Risk
Low; however, recurrent upper respiratory tract infections, allergies, and gastroesophageal reflux disease (GERD) can contribute to adenoid hypertrophy.